Search

everythinglearnresearchcommunity

for

Search:↓

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Autoimmune reactions may cause both alopecia areata and HAM.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.